127 related articles for article (PubMed ID: 29140750)
1. Postlicensure safety surveillance of congenital anomaly and miscarriage among pregnancies exposed to quadrivalent human papillomavirus vaccine.
Sy LS; Meyer KI; Klein NP; Chao C; Velicer C; Cheetham TC; Ackerson BK; Slezak JM; Takhar HS; Hansen J; Deosaransingh K; Liaw KL; Jacobsen SJ
Hum Vaccin Immunother; 2018 Feb; 14(2):412-419. PubMed ID: 29140750
[TBL] [Abstract][Full Text] [Related]
2. Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.
Arana JE; Harrington T; Cano M; Lewis P; Mba-Jonas A; Rongxia L; Stewart B; Markowitz LE; Shimabukuro TT
Vaccine; 2018 Mar; 36(13):1781-1788. PubMed ID: 29477308
[TBL] [Abstract][Full Text] [Related]
3. Maternal and infant outcomes following exposure to quadrivalent human papillomavirus vaccine during pregnancy.
Bukowinski AT; Hall C; Chang RN; Gumbs GR; Marie S Conlin A
Vaccine; 2020 Aug; 38(37):5933-5939. PubMed ID: 32712082
[TBL] [Abstract][Full Text] [Related]
4. Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy.
Lipkind HS; Vazquez-Benitez G; Nordin JD; Romitti PA; Naleway AL; Klein NP; Hechter RC; Jackson ML; Hambidge SJ; Lee GM; Sukumaran L; Kharbanda EO
Obstet Gynecol; 2017 Sep; 130(3):599-608. PubMed ID: 28796684
[TBL] [Abstract][Full Text] [Related]
5. Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes.
Kharbanda EO; Vazquez-Benitez G; DeSilva MB; Naleway AL; Klein NP; Hechter RC; Glanz JM; Donahue JG; Jackson LA; Sheth SS; Greenberg V; Panagiotakopoulos L; Mba-Jonas A; Lipkind HS
JAMA Netw Open; 2021 Apr; 4(4):e214340. PubMed ID: 33818618
[TBL] [Abstract][Full Text] [Related]
6. Risk of Spontaneous Abortion After Inadvertent Human Papillomavirus Vaccination in Pregnancy.
Kharbanda EO; Vazquez-Benitez G; Lipkind HS; Sheth SS; Zhu J; Naleway AL; Klein NP; Hechter R; Daley MF; Donahue JG; Jackson ML; Kawai AT; Sukumaran L; Nordin JD
Obstet Gynecol; 2018 Jul; 132(1):35-44. PubMed ID: 29889760
[TBL] [Abstract][Full Text] [Related]
7. Results on exposure during pregnancy from a pregnancy registry for AS04-HPV-16/18 vaccine.
López-Fauqued M; Zima J; Angelo MG; Stegmann JU
Vaccine; 2017 Sep; 35(40):5325-5330. PubMed ID: 28863867
[TBL] [Abstract][Full Text] [Related]
8. Risk of Guillain-Barré Syndrome following quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink.
Gee J; Sukumaran L; Weintraub E;
Vaccine; 2017 Oct; 35(43):5756-5758. PubMed ID: 28935469
[TBL] [Abstract][Full Text] [Related]
9. Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study.
Amend KL; Turnbull B; Zhou L; Marks MA; Velicer C; Saddier P; Seeger JD
Hum Vaccin Immunother; 2022 Nov; 18(5):2073750. PubMed ID: 35714277
[TBL] [Abstract][Full Text] [Related]
10. Safety of the HPV Bivalent and Quadrivalent Vaccines During Pregnancy.
Forinash AB; Yancey AM; Pitlick JM; Myles TD
Ann Pharmacother; 2011 Feb; 45(2):258-62. PubMed ID: 21285408
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study.
Chow EP; Danielewski JA; Fehler G; Tabrizi SN; Law MG; Bradshaw CS; Garland SM; Chen MY; Fairley CK
Lancet Infect Dis; 2015 Nov; 15(11):1314-23. PubMed ID: 26201300
[TBL] [Abstract][Full Text] [Related]
12. Incident autoimmune conditions among males receiving quadrivalent human papillomavirus vaccine in the United States.
Seeger JD; Amend KL; Turnbull BR; Zhou L; Marks MA; Velicer C; Saddier P
Vaccine; 2023 Mar; 41(11):1826-1833. PubMed ID: 36424257
[TBL] [Abstract][Full Text] [Related]
13. Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: Results to month 36 from a randomized trial.
Leung TF; Liu AP; Lim FS; Thollot F; Oh HML; Lee BW; Rombo L; Tan NC; Rouzier R; De Simoni S; Suryakiran P; Hezareh M; Thomas F; Folschweiller N; Struyf F
Vaccine; 2018 Jan; 36(1):98-106. PubMed ID: 29174109
[TBL] [Abstract][Full Text] [Related]
14. Unmasking in an observational vaccine safety study: Using type 2 diabetes mellitus as an example.
Ackerson BK; Sy LS; Slezak J; Chao CR; Hechter RC; Takhar HS; Jacobsen SJ
Vaccine; 2015 Nov; 33(46):6224-6. PubMed ID: 26440925
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review and Meta-analysis of Postlicensure Observational Studies on Human Papillomavirus Vaccination and Autoimmune and Other Rare Adverse Events.
Willame C; Gadroen K; Bramer W; Weibel D; Sturkenboom M
Pediatr Infect Dis J; 2020 Apr; 39(4):287-293. PubMed ID: 31876615
[TBL] [Abstract][Full Text] [Related]
16. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
Chow EPF; Machalek DA; Tabrizi SN; Danielewski JA; Fehler G; Bradshaw CS; Garland SM; Chen MY; Fairley CK
Lancet Infect Dis; 2017 Jan; 17(1):68-77. PubMed ID: 27282422
[TBL] [Abstract][Full Text] [Related]
17. Safety of quadrivalent human papillomavirus vaccine administered routinely to females.
Klein NP; Hansen J; Chao C; Velicer C; Emery M; Slezak J; Lewis N; Deosaransingh K; Sy L; Ackerson B; Cheetham TC; Liaw KL; Takhar H; Jacobsen SJ
Arch Pediatr Adolesc Med; 2012 Dec; 166(12):1140-8. PubMed ID: 23027469
[TBL] [Abstract][Full Text] [Related]
18. Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes.
Scheller NM; Pasternak B; Mølgaard-Nielsen D; Svanström H; Hviid A
N Engl J Med; 2017 Mar; 376(13):1223-1233. PubMed ID: 28355499
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine.
Chao C; Klein NP; Velicer CM; Sy LS; Slezak JM; Takhar H; Ackerson B; Cheetham TC; Hansen J; Deosaransingh K; Emery M; Liaw KL; Jacobsen SJ
J Intern Med; 2012 Feb; 271(2):193-203. PubMed ID: 21973261
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Quadrivalent Human Papillomavirus Vaccine Safety Using the Self-Controlled Tree-Temporal Scan Statistic Signal-Detection Method in the Sentinel System.
Yih WK; Maro JC; Nguyen M; Baker MA; Balsbaugh C; Cole DV; Dashevsky I; Mba-Jonas A; Kulldorff M
Am J Epidemiol; 2018 Jun; 187(6):1269-1276. PubMed ID: 29860470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
